The University of Dundee is to partner with global biopharmaceutical company Almirall to develop a novel approach against chronic and debilitating dermatology diseases where itch, or pruritus, plays a dominant role.
A novel vaccine production platform that could prove decisive in the battle against Streptococcus is among the University of Dundee innovations recognised in Scotland’s largest company creation programme for the higher education sector.